| AAP | acetaminophen |
| ALF | acute liver failure |
| HAV | hepatitis A virus |
| HBV | hepatitis B virus |
| HBc | hepatitis B core |
| HBs | hepatitis B surface |
| HCV | hepatitis C virus |
| HDOH | Hawaii Department of Health |
| HDS | herbal dietary supplement |
| HEV | hepatitis E virus |
| HILI | herb induced liver injury |
| FDA | Food and Drug Administration in Washington DC, USA |
| HAV | hepatitis A virus |
| HBV | hepatitis B virus |
| HBc | hepatitis B core |
| HBs | hepatitis B surface |
| HCV | hepatitis C virus |
| HDOH | Hawaii Department of Health |
| HDS | herbal dietary supplement |
| HEV | hepatitis E virus |
| HILI | herb induced liver injury |
| HSV | herpes simplex virus |
| LTs | liver tests |
| N | normal range as multiple of its upper limit |
| NAFLD | non-alcoholic fatty liver disease |
| NSAID | non-steroidal antiinflammatory drugs |
| OC | Oxy Cleanse |
| OEP | OxyELITE Pro |
| OLT | orthotopic liver transplantation |
| OTC | over the counter |
| PCP | primary care provider |
| PCR | polymerase chain reaction |
| PMH | past medical history |
| QMC | Queen’s Medical Center in Honolulu |
| RUCAM | Roussel Uclaf Causality Assessment Method |
| VZV | varicella zoster virus |